Construction of two new vectors for transformation of laboratory, natural and industrial Saccharomyces cerevisiae strains to trifluoroleucine and G418 resistance

. 2004 ; 49 (5) : 534-8.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid15702541

Two new plasmids, pEC3 and pECkan, were constructed and their use in yeast transformation described. Both plasmids are derivative of the pRS416 vector, in which the URA3 auxotrophic marker was replaced by the LEU4* gene (pEC3) or the kanMX4 gene (pECkan). pEC3 and pECkan plasmids transformed natural and commercial Saccharomyces cerevisiae strains to 5,5,5-trifluoro-DL-leucine and G418 (aminoglycoside related to gentamicin) resistance, respectively, with efficiency ranging from 10(-5) to 10(-7) transformants per number of viable cells. pEC3 transformed the Leu- laboratory strain, carrying the mutations leu4 leu9, to leucine prototrophy with efficiency of approximately 10(-4).

Zobrazit více v PubMed

Nucleic Acids Res. 1998 Aug 1;26(15):3611-3 PubMed

Yeast. 2002 Jan 15;19(1):17-28 PubMed

J Biotechnol. 2001 Dec 14;92(1):27-35 PubMed

Appl Microbiol Biotechnol. 2001 Sep;56(5-6):577-88 PubMed

Yeast. 1994 Dec;10(13):1793-808 PubMed

Genetics. 1989 May;122(1):19-27 PubMed

Mol Gen Genet. 1999 Feb;261(1):152-60 PubMed

FEMS Microbiol Lett. 1996 Apr 1;137(2-3):165-8 PubMed

Yeast. 1997 May;13(6):551-9 PubMed

Yeast. 1990 Nov-Dec;6(6):521-34 PubMed

FEMS Microbiol Lett. 1999 Nov 15;180(2):229-33 PubMed

FEBS Lett. 1998 Mar 20;425(1):117-22 PubMed

J Biol Chem. 1995 Mar 10;270(10):5270-5 PubMed

Methods Enzymol. 1991;194:319-29 PubMed

Yeast. 2000 Apr;16(6):539-45 PubMed

Yeast. 1998 Jan 30;14(2):115-32 PubMed

Folia Microbiol (Praha). 2003;48(4):496-500 PubMed

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...